लोड हो रहा है...

Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects

BACKGROUND: Aprocitentan is an orally active, dual endothelin (ET) receptor antagonist developed for the treatment of hypertension in which, despite available treatments, a medical need exists for drugs with a new mechanism of action. SUBJECTS AND METHODS: In this study, the single- and multiple-dos...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Drug Des Devel Ther
मुख्य लेखकों: Sidharta, Patricia N, Melchior, Meggane, Kankam, Martin K, Dingemanse, Jasper
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2019
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435120/
https://ncbi.nlm.nih.gov/pubmed/30962677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S199051
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!